Encouraging the outcomes of children with beta-thalassaemia major who underwent fresh cord blood transplantation from an HLA-matched sibling donor

References

• Locatelli F, Kabbara N, Ruggeri A, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013;122(6):1072–1078.
   PubMed Web of Science ®Google Scholar
• Gaziev J, Lucarelli G. Hematopoietic stem cell transplantation for thalassemia. Curr Stem Cell Res Ther. 2011;6(2):162–169.
   PubMed Web of Science ®Google Scholar
• Soni S, Boulad F, Cowan MJ, et al. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies. Pediatr Blood Cancer. 2014;61(9):1690–1694.
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling.Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources. N Engl J Med. 2000;342(25):1846–1854.
   PubMed Web of Science ®Google Scholar
• Pinto FO, Roberts I. Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol. 2008;141(3):309–324.
   PubMed Web of Science ®Google Scholar
• Wen J, Haque Q, Pei F, et al. Transplant outcomes in beta-thalassemia major patients receiving combined granulocyte colony-stimulating factor-primed bone marrow and cord blood graft compared to granulocyte colony-stimulating factor-primed bone marrow alone. Acta Haematol. 2018;140(1):20–29.
   PubMed Web of Science ®Google Scholar
• Tang X, Fang J, Yu J, et al. Clinical outcomes of unrelated cord blood transplantation in children with malignant and non-malignant diseases: multicenter experience in China. Pediatr Transplant. 2018;22(1):e13090.
   Web of Science ®Google Scholar
• Gluckman E, Ruggeri A, Volt F, et al. Milestones in umbilical cord blood transplantation. Br J Haematol. 2011;154(4):441–447.
   PubMed Web of Science ®Google Scholar
• Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol. 2009;147(2):262–274.
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105(3):1343–1347.
   PubMed Web of Science ®Google Scholar
• Jaing TH, Hung IJ, Yang CP, et al. Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia. Pediatr Transplant. 2009;13(6):766–768.
   PubMed Web of Science ®Google Scholar
• Wilkinson AC, Ishida R, Kikuchi M, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;571(7763):117–121.
   PubMed Web of Science ®Google Scholar
• Chen G, Yue A, Ruan Z, et al. Comparison of the effects of different cryoprotectants on stem cells from umbilical cord blood. Stem Cells Int. 2016;2016:1396783.
   PubMed Web of Science ®Google Scholar
• McManus MP, Wang L, Calder C, et al. Comparison of pre-cryopreserved and post-thaw-and-wash-nucleated cell count on major outcomes following unrelated cord blood transplant in children. Pediatr Transplant. 2012;16(5):438–442.
   PubMed Web of Science ®Google Scholar
• Locatelli F, De Stefano P. Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia. Haematologica. 2005;90(12):1592–1594.
   PubMed Web of Science ®Google Scholar
• Galambrun C, Pondarré C, Bertrand Y, et al. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions. Biol Blood Marrow Transplant. 2013;19(1):62–68.
   PubMed Web of Science ®Google Scholar
• Li C, Wu X, Feng X, et al. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation. Blood. 2012;120(19):3875–3881.
   PubMed Web of Science ®Google Scholar
• Sodani P, Gaziev D, Polchi P, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood. 2004;104(4):1201–1203.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825–828.
   PubMed Web of Science ®Google Scholar
• Johnson DB, Savani BN. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation? Exp Hematol. 2012;40(7):513–517.
   PubMed Web of Science ®Google Scholar
• Bizzetto R, Bonfim C, Rocha V, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than fanconi anemia. Haematologica. 2011;96(1):134–141.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100(5):1611–1618.
   PubMed Web of Science ®Google Scholar
• Ruggeri A, Eapen M, Scaravadou A, et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant. 2011;17(9):1375–1382.
   PubMed Web of Science ®Google Scholar
• Martin PL, Carter SL, Kernan NA, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006;12(2):184–194.
   PubMed Web of Science ®Google Scholar
• Jaing TH, Chen SH, Tsai MH, et al. Transplantation of unrelated donor umbilical cord blood for nonmalignant diseases: a single institution's experience with 45 patients. Biol Blood Marrow Transplant. 2010;16(1):102–107.
   PubMed Web of Science ®Google Scholar
• Herr AL, Kabbara N, Bonfim CM, et al. Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT. Blood. 2010;116(11):1849–1856.
   PubMed Web of Science ®Google Scholar
• Tan W, He Y, Feng X, et al. Thiotepa-based conditioning regimen compared to non-thiotepa conditioning regimen prior to allogeneic stem cell transplantation in β thalassemia major: impact on survival. Blood. 2018;132:2082–2082.
   Web of Science ®Google Scholar
• Boncimino A, Bertaina A, Locatelli F. Cord blood transplantation in patients with hemoglobinopathies. Transfus Apher Sci. 2010;42(3):277–281.
   PubMed Web of Science ®Google Scholar
• Ferrara JLM, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet (London, England). 2009;373(9674):1550–1561.
   PubMed Web of Science ®Google Scholar
• Lisini D, Zecca M, Giorgiani G, et al. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica. 2008;93(12):1859–1867.
   PubMed Web of Science ®Google Scholar
• Devolder K. Preimplantation HLA typing: having children to save our loved ones. J Med Ethics. 2005;31(10):582–586.
   PubMed Web of Science ®Google Scholar
• Samuel GN, Strong KA, Kerridge I, et al. Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do “saviour siblings” have in paediatric transplantation? Arch Dis Child. 2009;94(4):317–320.
   PubMed Web of Science ®Google Scholar
• Burgio GR, Nespoli L, Maccario R, et al. Conceiving a hematopoietic stem cell donor: twenty-five years after our decision to save a child. Haematologica. 2012;97(4):479–481.
   PubMed Web of Science ®Google Scholar
• Taylor-Sands M. Summary of saviour siblings. J Med Ethics. 2015;41(12):926.
   PubMed Web of Science ®Google Scholar
• Eyricha M, Schulzeb H. HLA matching in pediatric stem cell transplantation. Transfus Med Hemother. 2019;46:348–354.
   PubMed Web of Science ®Google Scholar
• Burgio GR, Locatelli F. Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics. Bone Marrow Transplant. 1997;19:1163–1168.
   PubMed Web of Science ®Google Scholar
• Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors? Transfusion. 2018;58:1427–1433.
   PubMed Web of Science ®Google Scholar
• Anthony Armson B, Allan DS, Casper RF. Umbilical cord blood: counselling,collection,and banking. J Obstet Gynaecol Can. 2015;37(9):832–844.
   PubMedGoogle Scholar